A new trading day began on Monday, with Hims & Hers Health Inc (NYSE: HIMS) stock price down -4.67% from the previous day of trading, before settling in for the closing price of $34.23. HIMS’s price has ranged from $8.09 to $35.02 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Consumer Defensive sector was 60.52%. Meanwhile, its annual earnings per share averaged 824.74%. With a float of $177.28 million, this company’s outstanding shares have now reached $209.44 million.
Considering the fact that the conglomerate employs 1046 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 77.58%, operating margin of 2.84%, and the pretax margin is 4.16%.
Hims & Hers Health Inc (HIMS) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Household & Personal Products Industry. The insider ownership of Hims & Hers Health Inc is 18.85%, while institutional ownership is 56.05%. The most recent insider transaction that took place on Dec 02 ’24, was worth 68,932. In this transaction Chief Commercial Officer of this company sold 2,054 shares at a rate of $33.56, taking the stock ownership to the 184,947 shares. Before that another transaction happened on Dec 02 ’24, when Company’s Chief Executive Officer sold 33,513 for $33.38, making the entire transaction worth $1,118,654. This insider now owns 33,502 shares in total.
Hims & Hers Health Inc (HIMS) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 824.74% per share during the next fiscal year.
Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators
Here are Hims & Hers Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.74. Likewise, its price to free cash flow for the trailing twelve months is 47.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.43, a number that is poised to hit 0.18 in the next quarter and is forecasted to reach 0.89 in one year’s time.
Technical Analysis of Hims & Hers Health Inc (HIMS)
Compared to the last year’s volume of 9.91 million, its volume of 13.48 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 73.35%. Additionally, its Average True Range was 2.97.
During the past 100 days, Hims & Hers Health Inc’s (HIMS) raw stochastic average was set at 88.91%, which indicates a significant increase from 84.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 124.04% in the past 14 days, which was higher than the 103.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.58, while its 200-day Moving Average is $18.54. Nevertheless, the first resistance level for the watch stands at $34.13 in the near term. At $35.62, the stock is likely to face the second major resistance level. The third major resistance level sits at $36.39. If the price goes on to break the first support level at $31.87, it is likely to go to the next support level at $31.10. Should the price break the second support level, the third support level stands at $29.61.
Hims & Hers Health Inc (NYSE: HIMS) Key Stats
With a market capitalization of 7.13 billion, the company has a total of 218,479K Shares Outstanding. Currently, annual sales are 872,000 K while annual income is -23,550 K. The company’s previous quarter sales were 401,560 K while its latest quarter income was 75,590 K.
